Recent progress in immunoisolated cell therapy

Biohybrid implalts represent a new class of medical device in which living cells, supported in a hydrogel matrix, and surrounded by semipepmiable membrane, produce and deliver therapeutic reagents tm specific sites wthin a host. First prpmsed in the mid‐1970s for tpeatment modality has progressed rapidly in the past four years and is now being investigated not just for endcrine disorders but also for alleviation of chronic pain, treatment of neurodegenerative disorders, and delivery of neurotrophic factors to sites withil the blood brain barrier, and aq a practical alternative to conventional ex vivo.

[1]  B A Solomon,et al.  Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. , 1991, Science.

[2]  C. Colton,et al.  Bioengineering in development of the hybrid artificial pancreas. , 1991, Journal of biomechanical engineering.

[3]  P. Lacy,et al.  Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. , 1991, Transplantation.

[4]  P. Tresco,et al.  Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats , 1991, Brain Research.

[5]  P. Aebischer,et al.  Repair of the blood-brain barrier following implantation of polymer capsules , 1991, Brain Research.

[6]  Shelley R. Winn,et al.  Transplantation of neural tissue in polymer capsules , 1988, Brain Research.

[7]  J. Sagen.  Chromaffin cell transplants for alleviation of chronic pain. , 1992, ASAIO journal.

[8]  W. Pusch,et al.  Synthetic Membranes—Preparation, Structure, and Application , 1982 .

[9]  G. Skjåk-Bræk,et al.  Long-term reversal of diabetes by the injection of immunoprotected islets. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Platt.  Mechanisms of tissue injury in hyperacute xenograft rejection. , 1992, ASAIO journal.

[11]  P. Sanberg,et al.  A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy , 1992, Neuroscience & Biobehavioral Reviews.

[12]  S K Young,et al.  Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue. , 1992, Transplantation proceedings.

[13]  M. Goosen,et al.  Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas , 1985, Biotechnology and bioengineering.

[14]  M. Lysaght,et al.  Future trends in renal replacement therapy. , 2008, Artificial organs.

[15]  C. Colton,et al.  Effect of Hypoxia on Insulin Secretion by Isolated Rat and Canine Islets of Langerhans , 1993, Diabetes.

[16]  P Aebischer,et al.  Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.

[17]  P. Tresco,et al.  Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease. , 1992, ASAIO journal.

[18]  G. Skjåk‐Braek,et al.  SUCCESSFUL REVERSAL OF SPONTANEOUS DIABETES IN DOGS BY INTRAPERITONEAL MICROENCAPSULATED ISLETS , 1992, Transplantation.

[19]  P. Tresco,et al.  Microencapsulated Bovine Chromaffin Cells In Vitro: Effect of Density and Coseeding with a NGF-Releasing Cell Line , 1992, Journal of neural transplantation & plasticity.

[20]  M J Lysaght,et al.  Artificial pancreas using living beta cells:. effects on glucose homeostasis in diabetic rats. , 1977, Science.

[21]  P. Lacy,et al.  Reversal of streptozotocin diabetes in nonimmunosuppressed mice with immunoisolated xenogeneic rat islets. , 1992, Transplantation proceedings.

[22]  Sugamori Me,et al.  Microencapsulation of pancreatic islets in a water insoluble polyacrylate. , 1989 .

[23]  P. Chang,et al.  Expression of human factor IX by microencapsulated recombinant fibroblasts. , 1993, Human gene therapy.

[24]  W. J. Tze,et al.  Long-term Survival of Adult Rat Islets of Langerhans in Artificial Capillary Culture Units , 1977, Diabetes.

[25]  B A Solomon,et al.  Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. , 1992, Endocrinology.

[26]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[27]  H. Auchincloss.  Xenogeneic transplantation. A review. , 1988, Transplantation.

[28]  M. Nicholas,et al.  Immunologic responses in central nervous system transplantation , 1992 .

[29]  A. Monaco,et al.  Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine, and porcine islets. , 1992, Transplantation proceedings.

[30]  P. Aebischer,et al.  Encapsulated thymic epithelial cells as a potential treatment for immunodeficiencies. , 1988, ASAIO transactions.

[31]  Shelley R. Winn,et al.  Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line , 1991, Experimental Neurology.

[32]  P. Chang,et al.  Delivery of recombinant gene products with microencapsulated cells in vivo. , 1993, Human gene therapy.

[33]  F T Gentile,et al.  Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. , 1991, Science.

[34]  G. Skjåk‐Braek,et al.  An immunologic basis for the fibrotic reaction to implanted microcapsules. , 1991, Transplantation proceedings.

[35]  T. Chang,et al.  Secretion of Erythropoietin from Microencapsulated Rat Kidney Cells: Preliminary Results , 1993, The International journal of artificial organs.

[36]  P R Sanberg,et al.  Encapsulated cell implantation for Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.

[37]  P. Aebischer,et al.  Mast cells and tissue reaction to intraperitoneally implanted polymer capsules. , 1991, Journal of biomedical materials research.

[38]  P. Tresco,et al.  Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  Patrick Aebischer,et al.  Transplantation of a Polymer-Encapsulated Cell Line Genetically Engineered to Release NGF , 1993, Experimental Neurology.